| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020344 |
| Receipt No. | R000023504 |
| Official scientific title of the study | A phase I clinical trial of carbon-ion radiotherapy using 4 fractions for hepatocellular carcinoma |
| Date of disclosure of the study information | 2015/12/25 |
| Last modified on | 2017/09/24 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | A phase I clinical trial of carbon-ion radiotherapy using 4 fractions
for hepatocellular carcinoma |
|
| Title of the study (Brief title) | A phase I clinical trial of carbon-ion radiotherapy using 4 fractions
for hepatocellular carcinoma |
|
| Region |
|
|
| Condition | ||||
| Condition | hepatocellular carcinoma | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Malignancy | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To evaluate the safety of carbon-ion radiotherapy using 4 fractions for hepatocellular carcinoma. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Dose-limiting toxicity
Acute toxicity(within 6 months) |
| Key secondary outcomes | Response rate
Late toxicity(6 months or later) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Carbon-ion radiation therapy
Total dose 60.0 Gy(RBE) 4 fractions |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) pathollogically or clinically diagnosed hepatocellular carcinoma.
2) The tumor is measurable and tumor size is 3cm or larger and less than 10cm. 3) Absence of major portal vein, inferior vena cava or bile duct invasion. 4) cN0M0 (accrdiong to UICC(International Union Against Cancer) TMN classification of Malignant tumours 7th edition) 5) At least 1 weeks passed after the previous therapy of hepatectomy, local ablation therapy or TACE. 6) Child-Pugh score of the patient is from 5 points to 9 points. 7) Perfomance status of the patient is from 0 to 2. 8) The patient is able to understand the explanation of the clinical trial and written informed concent is obtained. |
|||
| Key exclusion criteria | 1) History of radiation therapy to the lesion of interest.
2) The alimentary tract, major branch of portal vein or major bile duct was adjacent to the target lesion. 3) Patients with any other active malignancies. 4) Patient with severe comorbidity. |
|||
| Target sample size | 3 | |||
| Research contact person | |
| Name of lead principal investigator | Takashi Nakano |
| Organization | Gunma University |
| Division name | Heavy Ion Medical Center |
| Address | 3-39-22 Showa, Maebashi, Gunma |
| TEL | 027-220-8378 |
| tnakano@med.gunma-u.ac.jp | |
| Public contact | |
| Name of contact person | Tatsuya Ohno |
| Organization | Gunma University |
| Division name | Heavy Ion Medical Center |
| Address | 3-39-22 Showa, Maebashi, Gunma |
| TEL | 027-220-8378 |
| Homepage URL | |
| tohno@gunma-u.ac.jp | |
| Sponsor | |
| Institute | Gunma University Heavy Ion Medical Center
|
| Institute | |
| Department | |
| Funding Source | |
| Organization | MEXT |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023504 |